Etiracetam: Difference between revisions

Revision as of 17:38, 25 February 2016 editDePiep (talk \| contribs)Extended confirmed users294,285 editsm remove setting of the default value (\|drug_name=pagename) (via AWB script)← Previous edit		Revision as of 13:01, 26 February 2016 edit undoEdgar181 (talk \| contribs)Extended confirmed users196,325 edits \| chirality = Racemic mixture Next edit →
Line 2:		Line 2:
	{{Drugbox		{{Drugbox
	\| verifiedrevid = 443652033		\| verifiedrevid = 443652033
	\| IUPAC_name = (''RS'')-''2-(2-~~oxopyrrolidin~~-1-yl)butanamide''		\| IUPAC_name = (''RS'')-''2-(2-Oxopyrrolidin-1-yl)butanamide''
	\| image = Etiracetam structure.svg		\| image = Etiracetam structure.svg
	\| width = 106px		\| width = 106px
	\| image2 = Etiracetam3d.png		\| image2 = Etiracetam3d.png
	\| ~~caption~~ = ~~1 : 1~~ mixture ~~(racemate)~~		\| chirality = ]
	<!-- Clinical data -->		<!-- Clinical data -->
	\| tradename =		\| tradename =

Revision as of 13:01, 26 February 2016

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Etiracetam" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Pharmaceutical compound

Etiracetam
Clinical data


Routes of administration	Oral
ATC code	none
Legal status
Legal status	Unscheduled (US)
Identifiers
IUPAC name (RS)-2-(2-Oxopyrrolidin-1-yl)butanamide
CAS Number	33996-58-6
PubChem CID	59708
ChemSpider	53863
UNII	230447L0GL
ChEMBL	ChEMBL1400561
CompTox Dashboard (EPA)	DTXSID5046510
ECHA InfoCard	100.111.445
Chemical and physical data
Formula	C₈H₁₄N₂O₂
Molar mass	170.209 g/mol g·mol
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES CCC(C(=O)N)N1CCCC1=O
InChI InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) Key:HPHUVLMMVZITSG-UHFFFAOYSA-N
(verify)

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active enantiomeric form is levetiracetam.